MEK-ERK-Egr-1轴及其在心血管疾病中的调节
1Vascular Biology and Translational Research, Faculty of Medicine and Health, University of New South Wales, Sydney, NSW 2052, Australia.
Vascular pharmacology
|September 21, 2023
概括
MEK-ERK-Egr-1通路调节心血管疾病 (CVD) 的炎症. 针对这种级联的治疗为治疗心血管疾病提供了新的治疗策略,心血管疾病是导致死亡的主要原因.
科学领域:
- 分子生物学分子生物学
- 心血管研究研究心血管研究
- 生物化学 生物化学
背景情况:
- 心血管疾病 (CVD) 是一个主要的全球健康问题,导致严重的发病率和死亡率.
- 早期生长反应-1 (Egr-1),一种指转录因子,通过调节促炎过程,在心血管疾病的发病过程中起着至关重要的作用.
- EGR-1活动通过翻译后的修饰和酸化来调节,特别是通过MEK-ERK通路.
研究的目的:
- 审查了解MEK-ERK-Egr-1信号级联的最新进展.
- 在CVD的背景下,探索影响EGR-1活动的监管因素和代理人.
- 在这种心血管疾病干预途径中识别潜在的治疗点.
主要方法:
- 关于MEK-ERK-Egr-1级联的最新科学进展的文献综述.
- 对涉及影响EGR-1的各种因素和代理人的监管机制的分析.
- 综合了影响EGR-1的翻译后修改和激酶活性信息.
主要成果:
- MEK-ERK-Egr-1级联是心血管疾病中炎症过程的关键调节者.
- EGR-1活性受到各种因素的影响,包括TET2,TRIB2,MIAT,SphK1,cAMP,teneligliptin,胆固醇药物,红酒,黄类药物,沃贡因,费布克索斯塔特,多可萨赫萨酸和AT1R阻塞.
- 翻译后的修改,如sumoylation,ubiquitination和acetylation,进一步调节了EGR-1的功能.
结论:
- MEK-ERK-Egr-1途径为针对心血管疾病的新型治疗策略提供了一个有希望的目标.
- 了解各种因素对EGR-1的复杂调节,为药物开发开辟了道路.
- 针对这种级联可能会导致有效的干预措施,以减少心血管疾病发病率和死亡率.
相关概念视频
01:27Regulation of the Cardiovascular System
1.2K
The regulation of the cardiovascular system allows the body to adapt to various demands and maintain homeostasis.
The regulation of the cardiovascular system involves the autonomic nervous system (ANS), baroreceptors, and chemoreceptors, ensuring that heart rate and blood pressure are appropriately modulated in response to varying physiological demands.
The ANS comprises two main divisions: the sympathetic and parasympathetic nervous systems. The sympathetic nervous system enhances...
The regulation of the cardiovascular system involves the autonomic nervous system (ANS), baroreceptors, and chemoreceptors, ensuring that heart rate and blood pressure are appropriately modulated in response to varying physiological demands.
The ANS comprises two main divisions: the sympathetic and parasympathetic nervous systems. The sympathetic nervous system enhances...
1.2K
01:31Regulation of Heart Rates
1.9K
The regulation of heart rate is a complex process controlled by the autonomic nervous system (ANS), hormonal influences, and intrinsic cardiac mechanisms. The ANS has two main components: the sympathetic nervous system (SNS) and the parasympathetic nervous system (PNS).
The SNS increases heart rate through the release of norepinephrine and epinephrine, which act on beta-1 adrenergic receptors in the heart. This action increases the rate of depolarization in the sinoatrial (SA) node, the heart's...
The SNS increases heart rate through the release of norepinephrine and epinephrine, which act on beta-1 adrenergic receptors in the heart. This action increases the rate of depolarization in the sinoatrial (SA) node, the heart's...
1.9K
01:17Autoregulation of Blood Flow
2.4K
Autoregulation mechanisms are characterized by their inherent capacity for self-regulation without necessitating specific nervous stimulation or endocrine control. These mechanisms facilitate the adjustment of blood flow and, therefore, perfusion specific to each tissue region. This self-regulation encompasses chemical signals and myogenic controls.
Chemical Signaling in Autoregulation
Chemical signaling operates at the precapillary sphincter level, inciting either contraction or relaxation....
Chemical Signaling in Autoregulation
Chemical signaling operates at the precapillary sphincter level, inciting either contraction or relaxation....
2.4K
01:18Neural Regulation of Blood Pressure
2.9K
The neural regulation of blood pressure involves intricate interactions between the autonomic nervous system (ANS) and cardiovascular system, ensuring adequate perfusion of tissues. This regulation primarily occurs through baroreceptor and chemoreceptor reflexes, involving both short-term and long-term mechanisms.
Baroreceptor Reflex
Baroreceptors, located in the carotid sinuses and aortic arch, detect changes in blood pressure. When blood pressure rises, these stretch-sensitive receptors...
Baroreceptor Reflex
Baroreceptors, located in the carotid sinuses and aortic arch, detect changes in blood pressure. When blood pressure rises, these stretch-sensitive receptors...
2.9K
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
454
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
454
01:29Heart Failure II: Pathophysiology
14
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
14